It's good news that they're nearing the end of recruitment but having 150-155 patients is below their original 168 target.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025